Photo detail


Stories this photo appears in:

Xencor Inks Second Deal With Janssen Pharmaceuticals This Year

Monrovia-based biopharma company Xencor Inc. on Oct. 4 announced its second collaboration and license agreement with Janssen Biotech Inc. in 10 months — this one to develop and commercialize its drug candidate that stimulates T cells to treat certain types of lymphomas.

Tease photo